U.S. Machinery Stock News

QuantumScape launched its Eagle Line pilot production line, targeting scalable solid state battery output. The company integrated its Cobra manufacturing process into Eagle Line to support higher volume production. QuantumScape expanded agreements with major automotive OEMs and recorded its first customer billings. PowerCo shifted to a licensing only model with QuantumScape, changing the risk and capital mix of that relationship. The company moved into non automotive markets such as data...

CBL & Associates Properties (CBL) has just posted its FY 2025 third quarter numbers, with total revenue of US$139.3 million, basic EPS of US$2.44, and net income of US$74.3 million setting the tone for the latest update. The company has seen revenue move from US$125.1 million in Q3 FY 2024 to US$139.3 million in Q3 FY 2025, while trailing twelve month basic EPS stands at US$4.06, alongside a net profit margin of 22.3% versus 6.1% a year earlier, helped by a US$131.2 million one off gain...

AVITA Medical (RCEL) has just wrapped up FY 2025 with Q4 revenue of US$17.6 million, a basic EPS loss of US$0.38, and net income loss excluding extra items of US$11.6 million, giving investors a clear read on how the year finished. Over recent quarters, the company has seen revenue range from US$17.1 million to US$18.5 million, while quarterly basic EPS losses have moved between US$0.38 and US$0.53 as management pushes ahead with commercial execution and product launches. For investors, the...

Elanco Animal Health (NYSE:ELAN) announced that founding Chairman R. David Hoover will retire from the board and will not stand for re election. Dr. Deborah Kochevar, chair of the Innovation, Science and Technology committee, will also conclude her board service and not stand for re election. The leadership transition marks a change in board oversight following Hoover's role in guiding the company through its IPO and early years as a public company. Elanco Animal Health focuses on medicines...

Air Products and Chemicals paid its latest quarterly dividend of US$1.79 per share on February 9, 2026, extending a 44-year streak of annual dividend increases. However, dividend growth has slowed to around 1.1% and the company is relying on financing rather than free cash flow due to heavy hydrogen-related capital spending, raising questions about how long its dividend policy can be maintained on this basis. We’ll now examine how funding dividends through financing amid large hydrogen...

Recent performance snapshot Primo Brands (PRMB) has seen mixed share performance recently, with a 0.8% decline over the past day and a 4.4% decline over the past week, alongside gains over the past month and the past 3 months. See our latest analysis for Primo Brands. At a share price of US$18.76, Primo Brands has experienced near-term weakness, with 1-week and 1-day share price declines. However, its year-to-date share price return of 15.9% and 3-year total shareholder return of 25.5%...

Voyager Technologies (VOYG) has moved back into focus after securing a sixth patent tied to its Bishop Airlock, a new NASA Johnson Space Center services contract, and continued progress on the Starlab commercial space station. See our latest analysis for Voyager Technologies. All this has come during a choppy period for the shares, with a 30 day share price return of 24.17% decline and a 90 day share price return of 31.05% gain. This suggests momentum has cooled recently after a stronger...

Genesis Energy (GEL) has just wrapped up FY 2025 with fourth quarter revenue of US$440.8 million and basic EPS of US$0.04, alongside net income of US$5.0 million. Trailing 12 month figures show revenue of US$1.6 billion and a basic EPS loss of US$0.73. The company has seen quarterly revenue move from US$725.6 million in Q4 2024 to US$440.8 million in Q4 2025, with EPS shifting from a loss of US$0.58 per share to a small profit of US$0.04 per share over that period. Overall, the latest print...

Zebra Technologies (ZBRA) has wrapped up FY 2025 with fourth quarter revenue of US$1,475 million and basic EPS of US$1.39. Trailing 12 month figures show total revenue of US$5.4 billion and basic EPS of US$8.24. Over the past six reported quarters, revenue has ranged from US$1,255 million to US$1,475 million and quarterly basic EPS has moved between US$1.39 and US$3.16. This gives investors a clear view of how sales and per share earnings have tracked alongside a trailing net margin that has...

PG&E (PCG) closed out FY 2025 with fourth quarter revenue of US$6.8 billion, basic EPS of US$0.29 and net income of US$642 million, capping a trailing 12 month run of US$24.9 billion in revenue, EPS of US$1.18 and net income of US$2.6 billion. Over the past few quarters, the company has seen revenue move from US$6.0 billion in Q1 2025 to US$6.8 billion in Q4, alongside quarterly EPS ranging between US$0.24 and US$0.37. Trailing net margin sits at 10.4% versus 10.1% a year earlier, giving...

Studio City International Holdings (NYSE:MSC) has just reported third quarter FY 2025 results, posting revenue of US$182.5 million with a basic EPS loss of US$0.10, while trailing 12 month revenue sits at US$687.1 million against a full year EPS loss of US$0.34. Over recent quarters, revenue has moved from US$161.5 million in Q2 2024 to US$152.9 million in Q4 2024, then to US$161.7 million in Q1 2025, US$190.1 million in Q2 2025 and US$182.5 million in Q3 2025, with EPS losses ranging between...

Trupanion reported record results for 2025, with subscription revenue and subscription operating margins reaching new highs. The company plans to roll out a lower priced pet insurance product in response to ongoing veterinary cost inflation. Retention rates have improved, supported by pricing and communication efforts, and Trupanion has received Stevie Awards recognition for its customer service. Trupanion continues to invest in technology and initiatives such as Landspath to support growth...

Cooper-Standard Holdings (CPS) closed out FY 2025 with Q4 revenue of US$672.4 million and basic EPS of US$0.19, alongside net income of US$3.3 million excluding extra items. The company has seen quarterly revenue move from US$660.8 million in Q4 2024 to a range of US$667.1 million to US$706.0 million through FY 2025, while basic EPS has swung between a loss of US$0.43 in Q3 and a profit of US$0.19 in Q4, highlighting a story that focuses on how consistently those thin margins can be...

In February 2026, Rapid7, Inc. reported its fourth-quarter 2025 results, with revenue of US$217.39 million and net income of US$3.13 million, alongside full-year 2025 revenue of US$859.79 million and net income of US$23.38 million. The company also issued 2026 guidance that points to a GAAP loss in the first quarter but a return to GAAP profitability for the full year, giving investors fresh insight into its near-term growth and margin path. Now we’ll examine how Rapid7’s modest quarterly...

Brookfield Wealth Solutions (BNT) has wrapped up FY 2025 with Q4 revenue of about US$3.1b and basic EPS of roughly US$0.03, capping a year in which trailing 12 month revenue came in at US$11.6b and EPS at US$2.49. The company has seen quarterly revenue move between US$2.6b and US$3.1b across FY 2025, while basic EPS swung from a loss of US$0.90 in Q1 2025 to US$1.89 in Q3 2025 and US$0.03 in Q4 2025. This puts the focus on how consistently those earnings can convert into lasting...

Tyler Technologies (NYSE:TYL) announced the acquisition of For The Record, a company focused on digital court recording solutions. The company is rolling out early access to embedded AI features across its product set for interested clients. Tyler also introduced a new share repurchase program of up to US$1b. Tyler Technologies focuses on software and services for public sector clients, including courts, justice systems and local governments. By adding For The Record, the company is...

If you are wondering whether Halozyme Therapeutics at around US$79.44 is still attractively priced or starting to look expensive, this article takes a closer look at what the current market price might be implying. Over shorter horizons the stock has been mixed, with a 2.2% decline over the last 7 days, an 8.9% return over 30 days, a 13.0% return year to date, and a 36.3% return over 1 year. The 3 year and 5 year returns sit at 58.8% and 59.9% respectively. Recent interest in Halozyme...

Agnico Eagle Mines (NYSE:AEM) FY 2025 earnings snapshot Agnico Eagle Mines (NYSE:AEM) closed out FY 2025 with Q4 revenue of US$3.6 billion and basic EPS of US$3.04, while trailing twelve month revenue reached US$11.9 billion and EPS came in at US$8.89, alongside a 135.4% rise in earnings over the last year. Over recent periods, the company has seen revenue move from US$8.3 billion and EPS of US$3.79 on a trailing basis at the end of 2024 to US$11.9 billion and EPS of US$8.89 by Q4 2025, with...

If you are wondering whether Exact Sciences is still worth your attention at current prices, the key question is how its market value compares with what the business may be worth on paper. The stock last closed at US$103.24, with returns of 0.1% over 7 days, 1.0% over 30 days, 1.5% year to date, 109.4% over 1 year, 62.6% over 3 years, and a 30.2% decline over 5 years. Recent news around Exact Sciences has focused on its position in cancer diagnostics and how its core products fit into...

Karyopharm Therapeutics FY 2025 earnings snapshot Karyopharm Therapeutics (KPTI) closed FY 2025 with Q4 revenue of US$34.1 million and a basic EPS loss of US$5.68, alongside a net loss of US$102.2 million. On a trailing twelve month basis, EPS stood at a loss of US$17.93 on revenue of US$146.1 million and a net loss of US$196.0 million. The company has reported quarterly revenue ranging from US$30.0 million to US$44.0 million over the past year, with basic EPS losses between US$2.77 and...

Air Lease (NYSE:AL) is working through a pending merger with Sumisho Air Lease Corporation that could reshape how the business is organized and funded. The potential transaction raises questions around future operations, financing options, and how the combined entity might serve airline customers. Investors are watching closely as the company evaluates this merger alongside its current trading level near $64.73 per share. With Air Lease trading around $64.73, investors are weighing this...

Evolv Technologies Holdings (EVLV) has drawn fresh attention after securing new deployments of its AI-based weapons detection systems at major US sports venues, alongside appointing Axon executive Henrik Kühl to its board and audit committee. See our latest analysis for Evolv Technologies Holdings. The recent sports venue wins and board changes come after a mixed stretch for the stock, with a 7 day share price return of 3.46% but a 30 day share price decline of 13.68%. At the same time, the 1...

The Buckle, Inc. previously reported that net sales for the 4-week fiscal month ended January 31, 2026 rose 3.7% to US$61.8 million, with comparable store gains extending across the fourth quarter and full fiscal year. With full-year net sales increasing to US$1.30 billion and comparable store sales higher across all periods, Buckle’s latest update highlights consistent demand across its store base. Next, we’ll examine how this broad-based comparable sales growth may influence Buckle’s...

Redwood Trust (RWT) closed out FY 2025 with Q4 total revenue of US$87.3 million and basic EPS of US$0.14, marking a clear rebound from the loss making quarters seen earlier in the year. Over the past few periods, the company has seen revenue move from US$30.9 million in Q4 2024 to US$73.8 million in Q1 2025, fall to US$54.4 million in Q3, then climb to US$87.3 million in Q4. Basic EPS shifted from US$0.09 in Q1 2025 to a loss of US$0.76 in Q2 and back into positive territory in Q4. For...